scholarly article | Q13442814 |
P50 | author | Samba Reddy | Q71284431 |
P2093 | author name string | Ashwin Mohan | |
P2860 | cites work | The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors | Q24608726 |
The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female | Q24670092 | ||
Modification of seizure activity by electrical stimulation. II. Motor seizure | Q28236678 | ||
Progesterone receptor-mediated effects of neuroactive steroids | Q28263951 | ||
Progesterone receptors: form and function in brain | Q28274391 | ||
Progestin receptors mediate progesterone suppression of epileptiform activity in tetanized hippocampal slices in vitro | Q28582596 | ||
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities | Q29615568 | ||
Rapid kindling with recurrent hippocampal seizures | Q30467810 | ||
Transcriptional regulation of the mouse steroid 5alpha-reductase type II gene by progesterone in brain | Q33587653 | ||
Curing epilepsy: progress and future directions | Q33655266 | ||
Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters | Q33770744 | ||
From mirror focus to secondary epileptogenesis in man: an historical review | Q33802591 | ||
Neurosteroid withdrawal regulates GABA-A receptor α4-subunit expression and seizure susceptibility by activation of progesterone receptor-independent early growth response factor-3 pathway | Q34126206 | ||
A permanent change in brain function resulting from daily electrical stimulation | Q34225550 | ||
Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis | Q34238657 | ||
Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety | Q34419058 | ||
Three patterns of catamenial epilepsy | Q34467397 | ||
Reproductive functions of progesterone receptors. | Q34644047 | ||
Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy | Q34768821 | ||
Disease modification in partial epilepsy | Q34787087 | ||
Unfolding the action of progesterone receptors | Q35189965 | ||
Recent advances in understanding mechanisms of the kindling model | Q35900113 | ||
Steroid hormone fluctuations and GABA(A)R plasticity. | Q36101683 | ||
The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy | Q37227965 | ||
From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options | Q37383518 | ||
Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor | Q38303796 | ||
Gene expression of progesterone receptor isoforms in the rat brain | Q40513545 | ||
Hormonal regulation of atypical absence seizures. | Q40584096 | ||
Progestin receptor levels in rat hypothalamic and limbic nuclei | Q41609444 | ||
Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling | Q42654751 | ||
Stress within the postseizure time window inhibits seizure recurrence | Q43056655 | ||
Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. | Q43665513 | ||
Progestin receptor immunoreactivity within steroid-responsive vasopressin-immunoreactive cells in the male and female rat brain | Q44066546 | ||
Effects of tamoxifen, mifepristone and cyproterone on the electroconvulsive threshold and pentetrazole-induced convulsions in mice. | Q44077890 | ||
The anticonvulsant effects of progesterone and 5alpha-dihydroprogesterone on amygdala-kindled seizures in rats | Q44667874 | ||
Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. | Q44776094 | ||
Anxiolytic activity of progesterone in progesterone receptor knockout mice. | Q44861477 | ||
A high-performance liquid chromatography-tandem mass spectrometry assay of the androgenic neurosteroid 3alpha-androstanediol (5alpha-androstane-3alpha,17beta-diol) in plasma. | Q44863018 | ||
Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy | Q45284051 | ||
Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model | Q47248928 | ||
Evaluation of the anticonvulsant profile of progesterone in male amygdala-kindled rats | Q48433987 | ||
Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy | Q48494688 | ||
A pharmacological study in the kindling model of epilepsy | Q48615231 | ||
Endocrine defects in mice carrying a null mutation for the progesterone receptor gene | Q48619538 | ||
The effect of progesterone on kindling: a developmental study. | Q48626688 | ||
Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice | Q48851077 | ||
Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. | Q51479099 | ||
Estrogen-regulated progestin receptors are found in the midbrain raphe but not hippocampus of estrogen receptor alpha (ER alpha) gene-disrupted mice. | Q52541387 | ||
Persistence of kindling: effect of partial kindling, retention interval, kindling site, and stimulation parameters | Q70824156 | ||
Synergistic action of corticosterone on kainic acid-induced electrophysiological alterations in the hippocampus | Q71377869 | ||
The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics | Q72640463 | ||
Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform | Q74281193 | ||
Absence of gonadotropin surges and gonadotropin-releasing hormone self-priming in ovariectomized (OVX), estrogen (E2)-treated, progesterone receptor knockout (PRKO) mice | Q78086480 | ||
P433 | issue | 2 | |
P304 | page(s) | 650-658 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | Journal of Neuroscience | Q1709864 |
P1476 | title | Development and persistence of limbic epileptogenesis are impaired in mice lacking progesterone receptors | |
P478 | volume | 31 |
Q54981484 | 3β-Methyl-Neurosteroid Analogs Are Preferential Positive Allosteric Modulators and Direct Activators of Extrasynaptic δ-Subunit γ-Aminobutyric Acid Type A Receptors in the Hippocampus Dentate Gyrus Subfield. |
Q35996697 | A mouse kindling model of perimenstrual catamenial epilepsy |
Q49598739 | A novel therapeutic approach for treatment of catamenial epilepsy |
Q34893365 | A reliable method for intracranial electrode implantation and chronic electrical stimulation in the mouse brain |
Q35600228 | Antiseizure Activity of Midazolam in Mice Lacking δ-Subunit Extrasynaptic GABA(A) Receptors |
Q26752707 | Catamenial Epilepsy: Discovery of an Extrasynaptic Molecular Mechanism for Targeted Therapy |
Q47848096 | Catamenial-like seizure exacerbation in mice with targeted ablation of extrasynaptic δGABA-a receptors in the brain. |
Q37643528 | Clinical Potential of Neurosteroids for CNS Disorders. |
Q34975621 | Effects of progesterone on glutamate transporter 2 and gamma-aminobutyric acid transporter 1 expression in the developing rat brain after recurrent seizures |
Q42317501 | Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction |
Q36935313 | Estrous cycle regulation of extrasynaptic δ-containing GABA(A) receptor-mediated tonic inhibition and limbic epileptogenesis |
Q37225136 | Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions |
Q36240741 | Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis |
Q47920504 | Glial source of nitric oxide in epileptogenesis: A target for disease modification in epilepsy. |
Q36634134 | Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy |
Q36173874 | Neuroendocrine aspects of catamenial epilepsy |
Q36733535 | Neurosteroid Structure-Activity Relationships for Functional Activation of Extrasynaptic δGABA(A) Receptors. |
Q37320505 | Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability |
Q27026373 | Neurosteroids and their role in sex-specific epilepsies |
Q39126886 | Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy. |
Q47875905 | PR-independent neurosteroid regulation of α2-GABA-A receptors in the hippocampus subfields. |
Q34383389 | Perimenstrual-like hormonal regulation of extrasynaptic δ-containing GABAA receptors mediating tonic inhibition and neurosteroid sensitivity. |
Q93139568 | Plasma concentrations of steroid precursors, steroids, neuroactive steroids, and neurosteroids in healthy neonatal foals from birth to 7 days of age |
Q92234228 | Progesterone receptor activation regulates seizure susceptibility |
Q86551224 | Progesterone therapy in women with epilepsy |
Q38906926 | Prospects of modeling poststroke epileptogenesis. |
Q35971997 | Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy |
Q37057683 | Role of hormones and neurosteroids in epileptogenesis. |
Q88191048 | Role of β2/3-specific GABA-A receptor isoforms in the development of hippocampus kindling epileptogenesis |
Q36631870 | Seizure facilitating activity of the oral contraceptive ethinyl estradiol |
Q36179368 | Sex and hormonal influences on seizures and epilepsy |
Q37432122 | Sex differences in the anticonvulsant activity of neurosteroids |
Q37147577 | Zinc Selectively Blocks Neurosteroid-Sensitive Extrasynaptic δGABAA Receptors in the Hippocampus. |
Q93339679 | Zinc reduces antiseizure activity of neurosteroids by selective blockade of extrasynaptic GABA-A receptor-mediated tonic inhibition in the hippocampus |
Search more.